Hidradenitis Suppurativa

(asked on 12th July 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment NICE has made of the need for clinical guidelines on hidradenitis suppurativa.


This question was answered on 18th July 2016

The National Institute for Health and Care Excellence (NICE) has advised that it has not made any assessment of the need to develop a clinical guideline on the care of people with hidradenitis suppurativa, nor has it been asked to develop a clinical guideline on this condition.

NICE published technology appraisal guidance on adalimumab (Humira) for treating moderate to severe hidradenitis suppurativa (TA392) on 22 June 2016, which recommends its use. Commissioners now have three months in which to put in place funding arrangements.

Reticulating Splines